December 2011 | Cardiovascular Business

2012: Year of Cost-conscious Care

A more multidisciplinary and team-based approach in research and clinical settings. More use of registries and EMRs. More trends showing healthier patients. And above all others, more of a push to find value and cost savings in a changing reimbursement environment. Those are the take-home messages for the cardiovascular community from leaders in research, practice, government and business as they share their perspectives on 2012s challenges and opportunities.

2012: Time for the Resourceful

Every resourceful 10-year-old knows to search beneath couch cushions and check the pockets of last seasons coats to find overlooked cash.

Gender Disparities Persist with CAD

Coronary artery disease (CAD) is the leading cause of death in women. Yet, imaging remains inconsistent from the treatment of their male counterparts. Understanding gender differences in the physiology, symptoms and risk factors may help to reduce the gender gap and improve care.

Cardiac Implantable Devices Stamping Out Infections

Cardiovascular implantable electronic device (CIED) infections are hazardous and debilitating. The rate of these infections has swelled over the past decade, affecting patient outcomes and healthcare costs. Many questions remain, including the causes for this spike, and what strategies are most helpful to curb them.

CV Leaders Get Lean and Sigma-fied

Six Sigma and lean processes are more widely embraced by large and small healthcare providers. The key to their success is not the approaches themselves, but rather how they are applied.

ACC Corner | Innovation vs. FDA Process: At Odds?

As technologies advance, it is critical that our processes for evaluating them also evolve. This is no small task, but it is necessary to ensure that U.S. patients have access to medical care based on the most current science.

Select an Issue